Noroseal 2.6 g Intramammary Suspension for Cattle

Страна: Ірландія

мова: англійська

Джерело: HPRA (Health Products Regulatory Authority)

Активний інгредієнт:

Bismuth subnitrate, heavy

Доступна з:

Norbrook Laboratories (Ireland) Limited

Код атс:

QG52X

ІПН (Міжнародна Ім'я):

Bismuth subnitrate, heavy

Дозування:

2.6 g/syringe

Фармацевтична форма:

Intramammary suspension

Тип рецепту:

LR: Licensed Retailer as defined in national legislation

Терапевтична области:

VARIOUS PRODUCTS FOR TEATS AND UDDER

Статус Авторизація:

Authorised

Дата Авторизація:

2013-07-26

Характеристики продукта

Health Products Regulatory Authority
23 April 2019
CRN008XSP
Page 1 of 3
SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Noroseal 2.6 g Intramammary Suspension for Cattle
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
​
Each 4g Intramammary syringe contains:
​
​
Active substance:
​
​
Bismuth subnitrate, heavy
​
2.6g
​
For the full list of excipients, see section 6.1
​
3 PHARMACEUTICAL FORM
Intramammary suspension.
Light brown suspension.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Cattle (dairy cows)
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
Prevention of new intramammary infections throughout the dry period.
In cows considered likely to be free of sub-clinical mastitis, the
product may be suitable for use on its own in dry cow
management for mastitis control.
Selection of cows for treatment with the product should be based on
veterinary clinical judgement. Selection criteria may be
based on the mastitis and cell count history of individual cows, or
recognised tests for the detection of sub-clinical mastitis
such as bacteriological sampling.
4.3 CONTRAINDICATIONS
See section 4.7. Do not use in lactating cows. Do not use the product
alone in cows with sub-clinical mastitis at drying off. Do
not use in cows with clinical mastitis at drying off.
Do not use in cases of hypersensitivity to the active substance or to
any of the excipients.
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
None.
4.5 SPECIAL PRECAUTIONS FOR USE
(i) Special precautions for use in animals
It is good practice to observe dry cows regularly for signs of
clinical mastitis. If a sealed quarter develops clinical mastitis, the
affected quarter should be stripped out manually before appropriate
therapy is instituted.
To reduce the risk of contamination, do not immerse the syringe in
water.
Use the syringe only once.
It is important to observe strict aseptic technique for the
administration of the product, because the product does not have
antimicrobial activity.
Do not administer any other intramamma